Main View
This view is used for searching all possible sources.
First Page Previous Page 1 2 Next Page Last Page
 
1
Protective effect of andrographolide against concanavalin A-induced liver injury.
2011-09-24

This study was designed to investigate the hepatic protective effect and the molecular mechanisms of andrographolide in concanavalin A-induced liver injury model. Results showed that andrographolide (Ag) attenuated concanavalin A (Con-A)-induced liver injury and inhibited hepatocyte apoptosis. ...

PubMed

2
Suppression of cytochrome P450 gene expression in the livers of mice with concanavalin A-induced hepatitis.
2000-04-01

Cytochrome P450 (CYP) gene expression in the livers of mice with concanavalin A-induced hepatitis was examined. Treatment of mice with concanavalin A (10 mg/kg, i.v.) elevated plasma alanine aminotransaminase activity. In normal liver, CYP1A2, 3A and 2E1 mRNAs were expressed, and concanavalin A treatment differentially suppressed the ...

PubMed

3
Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids

immunomodulatory and anti-inflammatory properties. To see whether THC treatment prevents ConA-induced liver injury-deficient mice showed less severe liver tissue damage and less leukocyte infiltration upon ConA challenge (Fig. 9 April 2, 2008 ABSTRACT Immune-mediated liver diseases including ...

E-print Network

4
Critical role of interleukin-17/interleukin-17 receptor axis in mediating Con A-induced hepatitis.
2011-06-21

Concanavalin A (Con A)-induced hepatitis is thought to be a T-cell-mediated disease with active destruction of liver cells. Interleukin (IL)-17 is a cytokine produced principally by CD4(+) T cells. However, whether IL-17/IL-17 receptor (IL-17/IL-17R)-mediated responses are involved in T-cell-mediated Con A-induced ...

PubMed

5
The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injury.

In chronic viral hepatitis, autoimmune hepatitis, and some chronic cholestatic liver diseases, T-lymphocytes serve as effector cells of the immunostimulatory processes. Cellular interactions of immune cells with extracellular matrix (ECM) components are regulated primarily via the beta 1 subfamily of integrin receptors. The target epitope of several such integrin receptors is ...

PubMed Central

6
The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injury.

In chronic viral hepatitis, autoimmune hepatitis, and some chronic cholestatic liver diseases, T-lymphocytes serve as effector cells of the immunostimulatory processes. Cellular interactions of immune cells with extracellular matrix (ECM) components are regulated primarily via the beta 1 subfamily of integrin receptors. The target epitope of several such integrin receptors is ...

PubMed

7
Non-peptidic analogs of the cell adhesion motif RGD prevent experimental liver injury.
2000-07-01

In chronic viral hepatitis, autoimmune hepatitis, and some chronic cholestatic liver diseases, T lymphocytes serve as effector cells of the immunostimulatory processes. Cellular interactions of immune cells with extracellular matrix components are regulated primarily via the beta 1 subfamily of integrin receptors. The target epitope of several such integrin receptors is the ...

PubMed

8
The IL-6�gp130�STAT3 pathway in hepatocytes triggers liver protection in T cell�mediated liver injury
2005-04-01

Increasing evidence demonstrates that IL-6 has a protective role during liver injury. IL-6 activates intracellular pathways via the gp130 receptor. In order to identify IL-6�gp130 pathways involved in mediating liver protection, we analyzed hepatocyte-specific gp130 knockout mice in a concanavalin A�induced ...

PubMed Central

9
Co-exposure of lipopolysaccharide and Pseudomonas aeruginosa exotoxin A-induced multiple organ injury in rats.
2009-01-01

Pseudomonas aeruginosa Exotoxin A (PEA) induces hepatotoxicity in experimental animals. Lipopolysaccharide (LPS) interacts synergistically with xenotoxics to induce severe organ injury. We examined the combination of non-injurious doses of LPS and sub-hepatotoxic PEA in the induction of multiple organ injury (MOI). Rats treated with 20 ...

PubMed

10
Fumigaclavine C improves concanavalin A-induced liver injury in mice mainly via inhibiting TNF-alpha production and lymphocyte adhesion to extracellular matrices.
2004-06-01

Fumigaclavine C, an alkaloidal metabolite, was produced by Aspergillus fumigatus (strain No. CY018). This study examined the effect of this compound on concanavalin A (Con A)-induced liver injury in mice, a T cell-dependent model of liver damage. Con A administration resulted in severe liver ...

PubMed

11
Immunological tolerance in a mouse model of immune-mediated liver injury induced by 16,16 dimethyl PGE2 and PGE2-containing nanoscale hydrogels.
2011-04-08

Although immunosuppressive agents play a pivotal role in the success of organ transplantation, chronic toxicity has been a major issue for long-term treatment. The development of therapies that induce donor-specific immunological tolerance remains an important clinical challenge. In the present study, we investigated the underlying mechanisms and applications of prostaglandin (PG) E2 for the ...

PubMed

12
Acetaminophen Overdose and Liver Injury � Background and Options ...

Page 1. Acetaminophen Overdose and Liver Injury � Background and Options for Reducing Injury What Is the Problem? Acetaminophen ...

Center for Biologics Evaluation and Research (CBER)

13
Immunological aspects and therapeutic significance of an autoantibody against histone H1 in a rat model of concanavalin A-induced hepatitis
2010-04-01

We previously demonstrated the immunosuppressive activity of anti-histone H1 autoantibody induced in experimental and clinical liver allograft tolerance. This study aimed to explore the immunological aspects of anti-histone H1 autoantibody in liver injury induced by concanavalin A (Con A). To establish a Con A-hepatitis model, 20 mg/kg ...

PubMed Central

14
Curcumin protects mice against concanavalin A-induced hepatitis by inhibiting intrahepatic intercellular adhesion molecule-1 (ICAM-1) and CXCL10 expression.
2011-06-22

The effect of curcumin on liver injury caused by Concanavalin A (Con A) has not been carefully examined. This study was designed to evaluate the protective effect of curcumin on Con A-induced hepatitis in mice. Liver injured mice received curcumin by gavage at a dose of 200�mg/kg body weight before Con A ...

PubMed

15
T cell immunoglobulin- and mucin-domain-containing molecule-4 attenuates concanavalin A-induced hepatitis by regulating macrophage.
2010-05-07

Tim-4 is expressed primarily on APCs, including macrophages, and has been shown to play a critical role in T cell regulation. However, it remains unclear whether Tim-4 also plays a role in the regulation of macrophage functions. In the present study, we investigated the effects of Tim-4 on macrophage activity in Con A-induced hepatitis in mice. We found that high levels of ...

PubMed

16
Concanavalin A-induced liver injury triggers hepatocyte proliferation.
1998-05-01

Concanavalin A (Con A) injection into mice leads to immune-mediated liver injury. We studied whether after Con A-induced liver injury, TNF- and IL-6-dependent signaling pathways known to be related to hepatocyte proliferation are activated. 2 h after Con A injection, maximum TNF-alpha, and ...

PubMed Central

17
The protective action of scutellarin against immunological liver injury induced by concanavalin A and its effect on pro-inflammatory cytokines in mice.
2007-01-01

Scutellarin is a natural compound from a Chinese herb. The purpose of this paper was to study the protective effect of scutellarin on concanavalin A (Con A)-induced immunological liver injury and its effect on liver nuclear factor kappaB (NF-kappaB), tumor necrosis factor alpha (TNF-alpha), interferon gamma ...

PubMed

18
Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse.

Nicotinamide N-methyltransferase (NNMT), which converts nicotinamide (NA) to 1-methylnicotinamide (MNA), is up-regulated in the cirrhotic liver. Because MNA displays PGI(2)-dependent anti-inflammatory effects, the up-regulation of NNMT may play a regulatory role in liver inflammation. In the present work, we analyzed changes in NNMT activity in the ...

PubMed

19
Activated Kupffer cells play an important role in intra-hepatic Th1-associated necro-inflammation in Concanavalin A-induced hepatic injury in mice.
2003-10-01

BACKGROUND/AIMS: To examine whether or not activated Kupffer cells play an important role in intra-hepatic Th1-associated necro-inflammation in Concanavalin A (Con A)-induced hepatic injury in mice. METHODS: Con A was administered to Balb/c mice pretreated with or without gadolinium chloride (GdCl(3)). Kupffer cell activation was evaluated by their ability ...

PubMed

20
Protective Role of IL-33/ST2 Axis in Con A-Induced Hepatitis.
2011-05-18

BACKGROUND AND AIMS: We used Concanavalin A induced liver injury to study the role of Interleukin 33 and its receptor ST2 in the induction of inflammatory pathology and hepatocellular damage. METHODS: We tested susceptibility to Concanavalin A induced hepatitis in ST2 deficient and wild type BALB/c mice and analyzed the effects of single injection of ...

PubMed

First Page Previous Page 1 2 Next Page Last Page
 
First Page Previous Page 1 2 Next Page Last Page
 
21
Staphylococcal Enterotoxin A-Induced Hepatotoxicity Is Predominately Mediated by Fas Ligand (CD95L)
2004-12-01

Objective:To determine the role of tumor necrosis factor ? (TNF-?) and Fas ligand (FasL, CD95L) in superantigen-induced and endotoxin-induced liver injury.Summary Background Data:Gram-positive bacteria are increasingly common causes of sepsis and multiorgan failure, but the pathophysiologic mechanisms of superantigen-provoked hepatotoxicity remain ...

PubMed Central

22
Effects of intravenous immunoglobulins on T-cell mediated, concanavalin A-induced hepatitis in mice.
1997-12-01

Concanavalin A (ConA) activates T lymphocytes and causes T-cell mediated hepatic injury in mice. The intravenous administration of human immunoglobulins has beneficial effects in T-cell mediated diseases such as experimental autoimmune encephalomyelitis and adjuvant arthritis. In the present study, we examined the effects of intravenous immunoglobulins in a mouse model of ...

PubMed

23
HEGPOL: Randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312
2005-08-17

BackgroundKupffer cell-dependent ischemia / reperfusion (I/R) injury after liver transplantation is still of high clinical relevance, as it is strongly associated with primary dysfunction and primary nonfunction of the graft. Glycine, a non-toxic, non-essential amino acid has been conclusively shown in various experiments to prevent both activation of ...

PubMed Central

24
Injuries to the Liver: Analysis of 20 Cases
1972-01-15

Twenty cases of liver injury among 55 consecutive cases of abdominal injury submitted to laparotomy over a four-year period are reported. Forty-four of the cases were blunt injuries, and the cases of liver injury were in this group. Road traffic accidents accounted for 37 ...

PubMed Central

25
Overview of Eye Injuries

... Liver and Gallbladder Disorders Lung and Airway Disorders Men's Health Issues Mental Health ... Sports Injuries Heat Disorders Cold Injuries Radiation Injury Electrical ...

MedlinePLUS

26
Childhood Sports Injury Statistics

... Exhaustion and Heat Stroke Liver Injuries Teeth Injuries Anterior Cruciate Ligament (ACL) AC Joint Injuries Spinal Fracture Fractures ...

MedlinePLUS

27
Protective effect of chloral hydrate against lipopolysaccharide/D-galactosamine-induced acute lethal liver injury and zymosan-induced peritonitis in mice.
2010-05-25

In recent years, certain anesthetics have been shown to have protective effects against acute inflammation in experimental animals, an observation that may yield new options for adjunctive treatment of acute inflammation. In this study, we investigated the effects of chloral hydrate (CH) on the acute inflammatory response in BALB/c mice using lipopolysaccharide/D-galactosamine (LPS/D-GalN)-induced ...

PubMed

28
Protective effect of chloral hydrate against lipopolysaccharide/D-galactosamine-induced acute lethal liver injury and zymosan-induced peritonitis in mice.
2010-08-01

In recent years, certain anesthetics have been shown to have protective effects against acute inflammation in experimental animals, an observation that may yield new options for adjunctive treatment of acute inflammation. In this study, we investigated the effects of chloral hydrate (CH) on the acute inflammatory response in BALB/c mice using lipopolysaccharide/D-galactosamine (LPS/D-GalN)-induced ...

PubMed

29
Questions and Answers: Orlistat and Severe Liver Injury

... Questions and Answers: Orlistat and Severe Liver Injury. [5-26-2010]. Q1. ... Q5. How did FDA learn about the risk of severe liver injury? ...

Center for Drug Evaluation (CDER)

30
A humanized anti-osteopontin antibody protects from Concanavalin A induced-liver injury in mice.
2011-02-25

Osteopontin has been implicated in various inflammatory diseases including rheumatoid arthritis, multiple sclerosis, Crohn's disease, and fulminant hepatitis. Increased expression of osteopontin has been detected in pathological foci of these diseases. RA and fulminant hepatitis have been successfully treated by administration of neutralizing anti-osteopontin antibody in mice. However, rodent ...

PubMed

31
LIVER FUNCTION AND REGENERATION IN RATS X ...
1967-02-08

... excretion rate are not affected in animals irradiated at ... Descriptors : *LIVER, *RADIATION INJURIES, MITOSIS, REGENERATION(ENGINEERING ...

DTIC Science & Technology

32
Increased Translation in Liver Involves a Supernatant Factor ...
1973-01-03

... LASERS, *LIVER), (*RADIATION INJURIES, LASERS), PROTEINS, BIOSYNTHESIS, PEPTIDES, RIBOSOMES, RIBONUCLEIC ACIDS, CANADA. ...

DTIC Science & Technology

33
FDA Drug Safety Communication: Severe liver injury associated with ...

... Severe liver injury associated with the use of dronedarone (marketed as Multaq). ... in patients treated with dronedarone, including two post-marketing reports of ...

Center for Drug Evaluation (CDER)

34
Drugs sometimes cause serious injuries to the livers of ...

Drugs sometimes cause serious injuries to the livers of patients, with loss of hepatic function leading to illness, disability, hospitalization, and even ...

Center for Drug Evaluation (CDER)

35
Drug Safety Podcasts for Healthcare Professionals: Completed ...

... The decision to include information about severe liver injury in ... The following factors make confirming a cause-and-effect ... of liver injury and the need to see a ...

Center for Drug Evaluation (CDER)

36
FDA Drug Safety Communication: Liver injury warning to be removed ...

... Monthly liver enzyme testing (a blood test) is not ... may still order a liver enzyme test when it is ... Monthly pregnancy tests are still required for females of ...

Center for Drug Evaluation (CDER)

37
Environmental Aspects of Injury and Disease: Liver and Bile Ducts.
1976-01-01

The liver is a metabolically versatile organ that is responsible for the regulation of man's internal chemical environment. Exogenous and endogenous chemicals are absorbed, concentrated and then processed by the liver into more 'usable', storable, or excr...

National Technical Information Service (NTIS)

38
Role of sulphated polysaccharides from Sargassum Wightii in Cyclosporine A-induced oxidative liver injury in rats
2008-02-20

BackgroundSeaweeds or marine algae have long been made up a key part of the Asian diet, and as an antioxidant, sulphated polysaccharides have piqued the interest of many researchers as one of the ocean's greatest treasures. The present investigation suggests the therapeutic potential of sulphated polysaccharides from marine brown algae "Sargassum wightii" in Cyclosporine A ...

PubMed Central

First Page Previous Page 1 2 Next Page Last Page